In the Chair with Industry Leaders: Episode 3 – Tariffs and Economic Uncertainty: What’s Changing? In this episode of In the Chair with Industry Leaders, Matt Howard sits down once again […]
Read More
The Health Resources and Services Administration (HRSA) has approved a 340B Rebate Model Pilot Program that will significantly change how 340B discounts are accessed for covered entities for certain medications. […]
Read More
With the September 2, 2025, deadline for hospitals to submit revision requests to their Worksheet S-3 wage data for the Federal Fiscal Year (FFY) 2027 Wage Index now passed, and […]
Read More
At Blue & Co., we believe that our greatest strength lies in our people. Each member of our Medicare Bad Debt team brings a unique blend of expertise, experience, and […]
Read More
Since October of 2019, the Patient Driven Payment Model, or PDPM, has been the payment system for Medicare Part A in Skilled Nursing Facilities. Prior to this, payment was made […]
Read More
The Importance of Communication with the Team Medicaid is changing the way it pays for care in most states, but that doesn’t preclude us from treating patients and “providing care […]
Read More
The Centers for Medicare & Medicaid Services (CMS) require hospitals subject to the Inpatient Prospective Payment System (IPPS) to complete the Occupational Mix Survey (OMS) every three years. While CMS […]
Read More
Executive Summary The Centers for Medicare & Medicaid Services (CMS) has released the final version of the Minimum Data Set (MDS) 3.0 Resident Assessment Instrument (RAI) User’s Manual v1.20.1. This […]
Read More
As financial pressures continue to challenge hospitals and with many uncertainties still looming related to the “One Big Beautiful Bill,” hospitals must act now in looking at operational opportunities. The […]
Read More
Effective October 1, 2025 | CMS RAI Manual v1.20.1 The Centers for Medicare & Medicaid Services (CMS) has released the final version of the Minimum Data Set (MDS) 3.0 Resident Assessment […]
Read More
By Caleb Young, CPA, Manager at Blue & Co. The Advantage of Cost Segregation Studies For Real Estate Investment What if you could significantly increase your cash flow in the first year of […]
After nearly two months of uncertainty and legal challenges to the initial 340B rebate model pilot program, HRSA is now seeking public input on a future pilot program through March […]
Congress has again postponed the next PAMA clinical lab reporting period. Hospitals and outreach labs should still prepare. The new guidelines moved the reporting window to May 1, 2026, through […]
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.
